FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN DE MÁLAGA EN BIOMEDICINA Y SALUD (FIMABIS);CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS;FUNDACIÓ INSTITUT MAR D'INVESTIGACIONS MÈDIQUES
发明人:
Fernando RODRÍGUEZ DE FONSECA,Francisco Javier PAVÓN MORÓN,Juan Manuel DECARA DEL OLMO,Antonia SERRANO CRIADO,Jesús JOGLAR TAMARGO,Pedro CLAPÉS SABORIT,Rafael DE LA TORRE FORNELL,Magí FERRÉ ALBALADEJO
申请号：
US15529433
公开号：
US20180193293A1
申请日:
2015.11.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to the use of fatty acid amides with phenylalkylamines and of a pharmaceutical composition comprising at least one of these compounds in the prevention and/or treatment of fatty liver or a pathological condition or disease caused by fatty liver, either alcoholic or non-alcoholic, and, in particular, for the prevention and/or treatment of the alcoholic steatohepatitis or non-alcoholic steatohepatitis (NASH).
